Related references
Note: Only part of the references are listed.Wide Dissemination of GES-Type Carbapenemases in Acinetobacter baumannii Isolates in Kuwait
Remy A. Bonnin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates
A. Ghazawi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii
Nabil Karah et al.
DRUG RESISTANCE UPDATES (2012)
Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran
Amir Peymani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates
Andres Opazo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Association between β-Lactamase-Encoding blaOXA-51 Variants and DiversiLab Rep-PCR-Based Typing of Acinetobacter baumannii Isolates
Esther Zander et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait
N.A. Al-Sweih et al.
Journal of Infection and Public Health (2012)
Genomic Analysis of the Multidrug-Resistant Acinetobacter baumannii Strain MDR-ZJ06 Widely Spread in China
Hua Zhou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
High prevalence of unrelated multidrug-resistant Acinetobacter baumannii isolates in Pakistani military hospitals
Benjamin A. Evans et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007
Yvonne Pfeifer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
Jennifer M. Adams-Haduch et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Endemic Acinetobacter baumannii in a New York Hospital
Scott A. Weisenberg et al.
PLOS ONE (2011)
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Nicola C. Gordon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Global spread of carbapenem-resistant Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes
Ahmed Hamouda et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex
Kevin S. Akers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool
Laure Diancourt et al.
PLOS ONE (2010)
Worldwide Dissemination of the bla(OXA-23) Carbapenemase Gene of Acinetobacter baumanni
Pauline D. Mugnier et al.
EMERGING INFECTIOUS DISEASES (2010)
Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea
Kyungwon Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America
Thomas R. Fritsche et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii
B. A. Evans et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates
P. Mugnier et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Identification of PER-1 extended-spectrum β-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia
Balazs Libisch et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2008)
An increasing threat in hospitals:: multidrug-resistant Acinetobacter baumannii
Lenie Dijkshoorn et al.
NATURE REVIEWS MICROBIOLOGY (2007)
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species
Jane F. Turton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Is ISABA-1 customized for Acinetobacter?
H Segal et al.
FEMS MICROBIOLOGY LETTERS (2005)
Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii
SG Bartual et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Clinical features and epidemiology of Acinectobacter baumannii colonization and infection in Spanish hospitals
J Rodriguez-Baño et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobactetiaceae in Vietnam
V Cao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY -: The preantibiotic era has returned
D Landman et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Share Paper
